An illustrated guide to the methods of meta-analysis

Journal of Evaluation in Clinical Practice

Volumn 7, Issue 2, 2001, Pages 135-148

  Sutton, Alexander J ^a   Abrams, Keith R ^a   Jones, David R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Bayesian methods; Hospital discharge; Meta analysis; Methods; Re admission; Review

Indexed keywords

BAYES THEOREM; EVALUATION; HEALTH CARE; HEALTH SERVICES RESEARCH; HOSPITAL DISCHARGE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS;

BAYES THEOREM; HUMANS; META-ANALYSIS; PATIENT READMISSION; REPRODUCIBILITY OF RESULTS;

EID: 0035015964     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2753.2001.00281.x     Document Type: Review

References (66)

1. Begg C., Cho M., Eastwood S., Horton R., Moher O. & Olkin I. (1996) Improving the quality of reporting of randomised controlled trials: the CONSORT statement. Journal of the American Medical Association 276, 637-639.
2. Begg C.B. & Mazumdar M. (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101.
3. Berard A. & Bravo G. (1998) Combining studies using effect sizes and quality scores: application to bone loss in postmenopausal women. Journal of Clinical Epidemiology 51, 801-807.
4. Berger J.O. (1980). Statistical Decision Theory and Bayesian Analysis, 2nd edn. Springer-Verlag, New York.
5. Berkey C.S., Hoaglin D.C., Mosteller F. & Colditz G.A. (1995) A random-effects regression model for meta-analysis. Statistics in Medicine 14, 395-411.
6. Biggerstaff B.J. & Tweedie R.L. (1997) Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Statistics in Medicine 16, 753-768.
7. Boissel J.P., Blanchard J., Panak E., Peyrieux J.C., SACKS & H. (1989) Considerations for the meta-analysis of randomized clinical trials: summary of a panel discussion. Controlled Clinical Trials 10, 254-281.
8. Cochrane Effective Practice and Organisation of Care Review Group (1998) The Data Collection Checklist. University of Aberdeen, HSRU, Aberdeen.
9. Copas J. (1999) What works?: selectivity models and meta-analysis. Journal of the Royal Statistical Society, Series A 161, 95-105.
10. von Dadelszen P., Ornstein M.P, Bull S.B., Logan A.G., Koren G. & Magee L.A. (2000) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 355, 87-92.
11. Dear K.B.G. (1994) Iterative generalized least squares for meta-analysis of survival data at multiple times. Biometrics 50, 989-1002.
12. Decks J., Glanville J. & Sheldon T. (1996) Undertaking systematic reviews of research on effectiveness: CRD guidelines for those carrying out or commissioning reviews. Report no. 4. Centre for Reviews and Dissemination. York Publishing Services Ltd, York.
13. DerSimonian R. & Laird N. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials 7, 177-188.
14. Detsky A.S., Naylor C.D.O., Rourke K., McGeer A.J.L., Abbe K.A., O'Rourke K. & L'Abbe K.A. (1992) Incorporating variations in the quality of individual randomized trials into meta-analysis. Journal of Clinical Epidemiology 45, 255-265.
15. Dickersin K., Scherer R. & Lefebvre C. (1994) Systematic reviews - identifying relevant studies for systematic reviews. British Medical Journal 309, 1286-1291.
16. Droitcour J., Silberman G. & Chelimsky E. (1993) Cross-design synthesis: a new form of meta-analysis for combining results from randomized clinical trials and medical-practice databases. International Journal of Technology Assessment in Health Care 9, 440-449.
17. DuMouchel W.H. & Harris J.E. (1983) Bayes methods for combining the results of cancer studies in humans and other species (with comment). Journal of the American Statistical Association 78, 293-308.
18. Duval S. & Tweedie R. (1998) Practical estimates of the effect of publication bias in meta-analysis. Australasian Epidemiologist 5, 14-17.
19. Eddy D.M., Hasselblad V. & Shachter R. (1992) Meta-Analysis by the Confidence Profile Method. Academic Press, San Diego.
20. Egger M., Smith G.D., Schneider M. & Minder C. (1997) Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315, 629-634.
21. Fleiss J.L. (1993) The statistical basis of meta-analysis. Statistical Methods in Medical Research 2, 121-145.
22. Fleiss J.L. (1994) Measures of effect size for categorical data. In The Handbook of Research Synthesis (eds H. Cooper & L. V. Hedges), pp. 245-260. Russell Sage Foundation, New York.
23. Freemantle N., Cleland J., Young P., Mason J. & Harrison J. (1999) β-Blockade after myocardial infarction: systematic review and meta regression analysis. British Medical Journal 318, 1730-1737.
24. Givens G.H., Smith D.D. & Tweedie R.L. (1997) Publication bias in meta-analysis: a Bayesian data-augmentation approach to account for issues exemplified in the passive smoking debate. Statistical Science 12, 221-250.
25. Greenland S. (1987) Quantitative methods in the review of epidemiological literature. Epidemiological Review 9, 1-30.
26. Hardy R.J. & Thompson S.G. (1996) A likelihood approach to meta-analysis with random effects. Statistics in Medicine 15, 619-629.
27. Higgins J.P.T. & Whitehead A. (1996) Borrowing strength from external trials in a meta-analysis. Statistics in Medicine 15, 2733-2749.
28. Hollis S. & Campbell F. (1999) What is meant by intention to treat analysis? Survey of published randomised controlled trials. British Medical Journal 319, 670-674.
29. Horton R. (1997) Medical editors trial amnesty. Lancet 350, 756.
30. Horton R. & Smith R. (1999) Time to register randomised trials - the case is now unanswerable. British Medical Journal 319, 865-866.
31. Hunt M. (1997) How Science Takes Stock: the story of meta-analysis. Russell Sage Foundation, New York.
32. Irwig L., Macaskill P., Glasziou P. & Fahey M. (1995) Meta-analytic methods for diagnostic test accuracy. Journal of Clinical Epidemiology 48, 119-130.
33. Jefferson T., Mugford M., Gray A. & DeMicheli V. (1996) An exercise in the feasibility of carrying out secondary economic analysis. Health Economics 5, 155-165.
34. Juni P., Witschi A., Bloch R. & Egger M. (1999) The hazards of scoring the quality of clinical trials for meta-analysis. Journal of the American Medical Association 282, 1054-1060.
35. Katerndahl D.A. & Lawler W.R. (1999) Variability in meta-analytic results concerning the value of cholesterol reduction in coronary heart disease: a meta-meta-analysis. American Journal of Epidemiology 149, 429-441.
36. Larose D.T & Dey D.K. (1997) Grouped random effects models for Bayesian meta-analysis. Statistics in Medicine 16, 1817-1829.
37. Lau J., Ioannidis J.P. & Schmid C.H. (1998) Summing up evidence: one answer is not always enough. Lancet 351, 123-127.
38. Light R.J. & Pillemar D.B. (1984) Summing Up: the science of reviewing research. Harvard University Press, Cambridge, MA.
39. Midgette A.S., Wong J.B., Beshansky J.R., Porath A., Fleming C. & Pauker S.G. (1994) Cost-effectiveness of streptokinase for acute myocardial-infarction - a combined metaanalysis and decision-analysis of the effects of infarct location and of likelihood of infarction. Medical Decision Making 14, 108-117.
40. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D. & Stroup D. for the QUORUM Group (1999b) Improving the quality of reporting of meta-analysis of randomised controlled trials: the QUORUM statement. Lancet 354, 1896-1900.
41. Moher D., Jadad A.R., Nichol G., Penman M., Tugwell P. & Walsh S. (1995) Assessing the quality of randomized controlled trials - an annotated bibliography of scales and checklists. Controlled Clinical Trials 12, 62-73.
42. Moher D., Klassen T.P, Jadad A.R.,Tugwell P., Moher M. & Jones A.L. (1999a) Assessing the quality of randomised controlled trials: implications for the conduct of meta-analyses. Health Technology Assessment 3(12), 1-98.
43. O'Hagan A. (1988) Probability: methods and measurement. Chapman & Hall, London.
44. Oxman A.D. (1996) The Cochrane Collaboration Handbook: preparing and maintaining systematic reviews, 2nd edn. Cochrane Collaboration, Oxford.
45. Parker S.G., Peet S.M., McPherson A., Cannaby A.M., Baker R., Wilson A., Lindesay J., Parker G., Abrams K.R. & Jones D.R. (2001) A systematic review of discharge arrangements for older people. Health Technology Assessment (in press).
46. Peto R. (1987) Why do we need systematic overviews of randomised trials? Statistics in Medicine 6, 233-240.
47. Prevost T.C., Abrans K.R. & Jones D.R. (2000) Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening. Statistics in Medicine 19, 3359-3376.
48. Roberts K.A., Jones D.R., Abrams K.R., Dixon-Woods M. & Fitzpatrick R. (1998) Meta-analysis of qualitative and quantitative evidence: an example based on studies of patient satisfaction. Technical Report 98-01, University of Leicester: Department of Epidemiology and Public Health, Leicester.
49. Rubin D. (1992) A new perspective. In The Future of Meta-Analysis (eds K.W. Wachter & M.L. Straf), pp. 155-165. Russell Sage Foundation, New York.
50. Schmid C.H., Lau J., McIntosh M.W. & Cappelleri J.C. (1998) An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials. Statistics in Medicine 17, 1923-1942.
51. Schulz K.F., Chalmers I., Hayes R.J. & Altman D.G. (1995) Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 273, 408-412.
52. Senn S., Sharp S., Thompson S. & Altman D. (1996) Relation between treatment benefit and underlying risk in meta-analysis. British Medical Journal 313, 1550-1551.
53. Shadish W.R. & Haddock C.K. (1994) Combining estimates of effect size. In The Handbook of Research Synthesis (eds H. Cooper & L.V. Hedges), pp. 261-284. Russell Sage Foundation, New York.
54. Song F., Easterwood A., Gilbody S., Duley L. & Sutton A.J. (2000) Publication and other selection biases in systematic reviews. Health Technology Assessment 4(10), 1-115.
55. Spiegelhalter D.J., Miles J.P., Jones D.R. & Abrams K.R. (2000a) Bayesian methods in health technology assessment. Health Technology Assessment 4(38), 1-142.
56. Spiegelhalter D.J., Thomas A. & Best N.G. (2000b) Winbugs, version 1.2. user manual. MRC Biostatistics Unit, Cambridge.
57. Sterne J.A.C., Egger M. & Sutton A.J. (2001) Meta-analysis software. In Systematic Reviews in Health Care: meta-analysis in context, 2nd edn (eds M. Egger, G. Davey Smith & D.G. Altman), pp. 336-346. BMJ Books, London.
58. Stewart L.A. & Clarke M.J. (1995) Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group on Statistical Medicine 14, 2057-2079.
59. Sutton A.J., Abrams K.R., Jones D.R., Sheldon T.A. & Song F. (1998) Systematic reviews of trials and other studies. Health Technology Assessment 2(19), 1-310.
60. Sutton A.J., Abrams K.R., Jones D.R., Sheldon T.A. & Song F. (2000c) Methods for Meta-Analysis in Medical Research. John Wiley, London.
61. Sutton A.J., Duval S.J., Tweedie R.L., Abrams K.R. & Jones D.R. (2000a) Empirical assessment of effect of publication bias on meta-analyses. British Medical Journal 320, 1574-1577.
62. Sutton A.J., Lambert P.C., Hellmich M., Abrams K.R. & Jones D.R. (2000b) Meta-analysis in practice: a critical review of available software. In Meta-Analysis in Medicine and Health Policy (eds D.A. Berry & D.K. Stangl). Marcel Dekker, New York.
63. Thompson S.G. (1993) Controversies in meta-analysis: the case of the trials of serum cholesterol reduction. Statistical Methods in Medical Research 2, 173-192.
64. Tweedie R.L. & Mengersen K.L. (1995) Meta-analytic approaches to dose-response relationships, with application in studies of lung cancer and exposure to environmental tobacco smoke. Statistics in Medicine 14, 545-569.
65. Walter S.D. (1997) Variation in baseline risk as an explanation of heterogeneity in meta-analysis. Statistics in Medicine 16, 2883-2900.
66. Whitehead A. & Jones N.M.B. (1994) A meta-analysis of clinical trials involving different classifications of response into ordered categories. Statistics in Medicine 13, 2503-2515.